TABLE 1

Distribution of Animals in Various Studies

Experimental purposeAnimal groupsMeasurements made
64Cu handling in first hourLEA rats (n = 15)Tail vein (n = 3) or intrasplenic injection of 64Cu (n = 12)
LEC+/− rats (n = 15)Blood sampling at 15, 30, 45, and 60 min
LEC−/− rats (n = 15)Bile collection × 60 min
Tissue sampling
64Cu handling over 2–24 hLEA rats (n = 9)Blood sampling at 2, 3, and 24 h
LEC+/− rats (n = 9)Bile collection × 60 min after 2, 3, and 24 h
LEC−/− rats (n = 9)Tissue sampling
Small-animal PET studiesLEA rats (n = 9)Imaging at 1, 3, and 24 h
LEC+/− rats (n = 9)Bile collection × 60 min after 1, 3, and 24 h
LEC−/− rats (n = 9)Tissue sampling
Liver injury and 64Cu handlingHealthy LEA rats (n = 6)99mTc-mebrofenin imaging
LEA rats, acute injury (n = 6)Blood sampling at 15, 30, 45, and 60 min and 3 h
F344 rats, chronic injury (n = 9)Bile collection × 60 min after 1 and 3 h
Tissue sampling
Effect of drugs on 64Cu excretionLEA rats, valproic acid (n = 6)Bile collection × 60 min
LEA rats, hydrocortisone (n = 3)Tissue sampling
Cell transplantation studiesLEC rats (n = 10)Bile collection × 60 min
Tissue sampling
Small-animal PET